Search database
Filter
26
Text search: astra
Featured
Language
Document type
Fact sheets
7
Studies & Reports
5
Guidelines
5
Resource Platforms
3
No document type
3
Situation Updates
2
Strategic & Response Plan
1
Countries / Regions
Ukraine
2
East and Southern Africa
2
West and Central Africa
2
South Sudan
1
Syria
1
Kenya
1
Brazil
1
Colombia
1
Madagascar
1
South–East Asia Region
1
Paraguay
1
Africa
1
Global
1
South Korea
1
Authors & Publishers
World Health Organization WHO
5
Africa CDC Centres for Disease Control and Prevention
3
African Union
3
European Medicines Agency EMA
2
World Health Organization WHO, et al.
2
World Health Organization WHO, Regional Office of Europe
2
Agence du Médicament de Madagascar
1
and I. Feijo
1
Asean Briefing
1
Bousquet, J.
1
Greinacher, A., et al.
1
IACAPAP
1
Internews
1
J.
1
Khaltaev, N.
1
Kishimoto T., Robenzadeh A, Leucht C, et al.
1
materia socio-medica
1
Ministerio de Salud Pública, Paraguay
1
Ministry of Health
1
Office for the Coordination of Humanitarian Affairs OCHA
1
OPAS
1
OPAS, OMS
1
Selma Azabagic, Razija Spahic, Nurka Pranjic, and Maida Mulic
1
Starling
1
World Health Organisation (WHO)
1
World Health Organization (WHO)
1
Publication Years
Category
Countries
10
Public Health
1
Clinical Guidelines
1
Toolboxes
COVID-19
16
Conflict
4
Mental Health
2
NCDs
2
Disability
1
Rapid Response
1
Caregiver
1
2.0 Rapid Response
1
 Download
  View PDF
 Add to my

Déclaration sur l’efficacité du vaccin COVID-19 d’AstraZeneca (ChAdOx1 nCoV-19) contre les variants du SARS-CoV-2
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2021) C1
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
 External Link
 Add to my

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Greinacher, A., et al. (2021) CC
New England Journal of Medicine April 9, 2021 DOI: 10.1056/NEJMoa2104840
 External Link
 Add to my

WHO Recommendation AstraZeneca/SKBio - COVID-19 Vaccine (ChAdOx1-S [recombinant])

World Health Organization WHO (2021) C_WHO
 External Link
 Add to my

Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine

World Health Organization WHO (2021) C_WHO
7 April 2021 Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed. Available in Englisch, French and Russian
 Download
  View PDF
 Add to my

Africa Regulatory Taskforce has Endorsed the Emergency Used Listing for Two Versions of the AstraZeneca-Oxford Vaccine

African Union; Africa CDC Centres for Disease Control and Prevention; World Health Organization WHO, et al. (2021) C1
AstraZeneca-SKBio in South Korea and Serum Institute of India
 External Link
 Add to my

Documentos técnicos Vacunación

Ministerio de Salud Pública, Paraguay (2022) C1